ea0065p286 | Neuroendocrinology | SFEBES2019
Dutta Pinaki
, Gupta Nidhi
, Rai Ashutosh
, Vaiphei Kim
, Dhandapani SS
, Ahuja Chirag K
, Bhansali Anil
Objective: To study O6-methylguanine-DNA methyltransferase (MGMT) immunoexpression to access the efficacy of Temozolamide (TMZ) as a part of multimodality treatment.Background: Aggressive or residual pituitary tumours are associated with substantial morbidity. Treatment options are often limited, and chemotherapy are associated with dismal results. Recent reports have documented the efficacy of TMZ therapy in aggressive pituitary tumors resistant to mult...